PPT-11/29/2017 1 Good Dispensing Practices

Opening Remarks Welcome and opening prayer Remarks by 1 2 3 11292017 2 Facilitator and Participants introduction Prof Gustav Malangu is a public health an International Health pharmacy practice specialist with more than 15 years experience as a trainer technical advisor and practising pharmacist. How it can benefit patients and practices.... A typical repeat prescribing system . GP decides to issue prescription which can be repeated . X. times. Patient’s record in GP clinical system contains authority for . Behind Bars. Implementation . of Barcode . Scanning . In Pharmacy Departments. Released July 2014. The Good Pharmacist. Pharmacists are by nature (usually) very careful . Jeff Kiger, . “. Pharmacist: The perfect job for a perfectionist. Glennis P. Gray, RN-BC, BSN, MSN. Ann Savwoir, RPh. Rhonda LeMora, MPA. Wanda P. Rose, JD, MPH. PRESENTERS. DISCLOSURE. I have no financial interests or other relationship with manufacturers of commercial products, suppliers of commercial services, or commercial supporters. My presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.. 19 November . . 2015. Survey carried out July/August 2015. 59. (39%) out of 152. Total Responses. Training Needs Survey. /14 = 38%. /23 = 70%. /26 = 38%. /29 = 48%. /60 = 23%. Q3: Flu Vaccination Training (annual). September 2016. Implementation Timeline. Office of Compassionate Use Established. : July 1, 2014. Florida Administrative Code Chapter 64-4 Promulgated, Final Rule Upheld: . May 28, 2015. Dispensing Organization Applications Accepted: . Dr Richard West. Chairman DDA. Chairman Suffolk LMC. Dispensing doctor. GP. Pharmacy owner. 2. Agenda. Pharmacy . C. ontract. Dispensing Fee. Reimbursement. CQC. EPS. Falsified . M. edicines . D. irective. Agenda. EPS Overview & Update . eRD & the Benefits. Patient Selection & Synchronisation. How does it work - Animation. eRD Prescribing and cancelling – basic principles. . Questions & Feedback?. Glennis P. Gray, RN-BC, BSN, MSN. Ann Savwoir, RPh. Rhonda LeMora, MPA. Wanda P. Rose, JD, MPH. PRESENTERS. DISCLOSURE. I have no financial interests or other relationship with manufacturers of commercial products, suppliers of commercial services, or commercial supporters. My presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.. 11/29/2017. 1. Introduction. Medication errors responsible for numerous adverse outcomes, including death. This results in high cost (emotional and financial). General framework for handling dispensing errors. A Guide to Preparedness . Version 11. Jim Sowards, WV SNS Coordinator. Humbert Zappia, CDC Public Health Advisor. Assumptions. Everyone attending this presentation has existing knowledge of the Strategic National Stockpile program and its purpose.. -Job Des -Updated 07/2014JOB DESCRIPTIONTITLEDispensing NurseCLASSIFICATIONFull-time/Non-Exempt/375 hoursIMMEDIATE SUPERVISORProgram ManagerPROGRAM/DEPARTMENTMethadoneSUMMARY OF POSITION RESPONSIBILIT Slide 1Slide 2Ordering investigator has an active CTEP registrationOrdering investigator is study-eligibleIf study prescription is written by study staff it is co-signed by a registered study-eligible Revised 09/2017Oregon Medical Board 1500 SW 1stAve Suite 620 Portland Oregon 97201Phone 9716732700 or 8772546263Fax 9716732672 wwwOregongov/OMBLast NameFirst NameMiddle NameMailing Address StreetCi Utah CodePage 11a Cosmetic drug means a prescription drug thati is for the purpose of promoting attractiveness or altering the appearance of an individual andiiA is listed as a cosmetic drug subject t